HEADER OXIDOREDUCTASE 22-AUG-05 2BZS TITLE BINDING OF ANTI-CANCER PRODRUG CB1954 TO THE ACTIVATING ENZYME NQO2 TITLE 2 REVEALED BY THE CRYSTAL STRUCTURE OF THEIR COMPLEX. COMPND MOL_ID: 1; COMPND 2 MOLECULE: NRH DEHYDROGENASE [QUINONE] 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NRH QUINONE OXIDO-REDUCTASE TYPE 2, QUINONE REDUCTASE 2, COMPND 5 QR2, NRH QUINONE OXIDOREDUCTASE 2; COMPND 6 EC: 1.6.99.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: TOP10; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PMTL1013; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PMTL1015 KEYWDS OXIDOREDUCTASE, NQO2, CB1954, FAD, FLAVOPROTEIN, METAL-BINDING, KEYWDS 2 POLYMORPHISM, ZINC EXPDTA X-RAY DIFFRACTION AUTHOR M.M.ABU KHADER,J.T.HEAP,C.DE MATTEIS,B.KELLAM,S.W.DOUGHTY,N.MINTON, AUTHOR 2 M.PAOLI REVDAT 5 13-DEC-23 2BZS 1 REMARK HETSYN LINK REVDAT 4 12-DEC-18 2BZS 1 REMARK HETSYN REVDAT 3 24-FEB-09 2BZS 1 VERSN REVDAT 2 30-NOV-05 2BZS 1 JRNL REVDAT 1 23-SEP-05 2BZS 0 JRNL AUTH M.M.ABU KHADER,J.T.HEAP,C.DE MATTEIS,B.KELLAM,S.W.DOUGHTY, JRNL AUTH 2 N.MINTON,M.PAOLI JRNL TITL BINDING OF THE ANTICANCER PRODRUG CB1954 TO THE ACTIVATING JRNL TITL 2 ENZYME NQO2 REVEALED BY THE CRYSTAL STRUCTURE OF THEIR JRNL TITL 3 COMPLEX. JRNL REF J.MED.CHEM. V. 48 7714 2005 JRNL REFN ISSN 0022-2623 JRNL PMID 16302811 JRNL DOI 10.1021/JM050730N REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 34512 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1813 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2377 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2740 REMARK 3 BIN FREE R VALUE SET COUNT : 106 REMARK 3 BIN FREE R VALUE : 0.3210 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3648 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 144 REMARK 3 SOLVENT ATOMS : 299 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.54 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.47 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.08000 REMARK 3 B22 (A**2) : -2.89000 REMARK 3 B33 (A**2) : -0.20000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.190 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.175 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.122 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.314 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3902 ; 0.017 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5322 ; 1.865 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 458 ; 7.386 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 172 ;34.426 ;24.186 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 612 ;14.808 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;23.974 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 560 ; 0.119 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2978 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1896 ; 0.219 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2652 ; 0.314 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 267 ; 0.212 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 87 ; 0.309 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 134 ; 0.698 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2364 ; 1.134 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3696 ; 1.782 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1882 ; 2.606 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1620 ; 4.066 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. RESIDUES 51-59 ARE DISORDERED. DISORDERED REGIONS REMARK 3 WERE MODELED STEREOCHEMICALLY. THIS ENTRY CONTAINS SOME ATOMS REMARK 3 WITH ZERO OCCUPANCY FOR WHICH THE B-FACTORS HAVE BEEN REFINED. REMARK 4 REMARK 4 2BZS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-AUG-05. REMARK 100 THE DEPOSITION ID IS D_1290025063. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-05 REMARK 200 TEMPERATURE (KELVIN) : 93.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : VARIMAX HF REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36382 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1QR2 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.66M AMM. SULF IN 100MM NA-HEPES PH 7 REMARK 280 AND 12MICROM FAD, 1MM DTT, PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 40.41500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.82500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.05500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.82500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.41500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.05500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE ENZYME HAS A POSSIBLE ROLE AS A QUINONE REDUCTASE REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A -5 REMARK 465 HIS A -4 REMARK 465 ALA A -3 REMARK 465 ILE A -2 REMARK 465 ASN A -1 REMARK 465 ALA A 0 REMARK 465 CYS B -5 REMARK 465 HIS B -4 REMARK 465 ALA B -3 REMARK 465 ILE B -2 REMARK 465 ASN B -1 REMARK 465 ALA B 0 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 GLY B 57 REMARK 475 THR B 58 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2048 O HOH A 2119 1.01 REMARK 500 O HOH A 2014 O HOH A 2015 1.07 REMARK 500 O HOH B 2091 O HOH B 2092 2.10 REMARK 500 O HOH A 2023 O HOH A 2046 2.13 REMARK 500 O HOH B 2020 O HOH B 2023 2.16 REMARK 500 O HOH A 2024 O HOH A 2077 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 CG2 THR B 58 CG GLU B 218 4556 1.67 REMARK 500 OG1 THR B 58 CB GLU B 218 4556 1.81 REMARK 500 OG1 THR B 58 CG GLU B 218 4556 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 118 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ARG B 118 NE - CZ - NH2 ANGL. DEV. = -4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 107 -165.88 -160.90 REMARK 500 TYR A 132 -127.85 57.51 REMARK 500 THR B 58 119.64 -38.71 REMARK 500 SER B 60 -70.38 -46.78 REMARK 500 ARG B 78 57.58 37.12 REMARK 500 TYR B 132 -117.01 43.09 REMARK 500 TYR B 155 53.08 -97.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 229 GLN A 230 48.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 231 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 173 ND1 REMARK 620 2 HIS A 177 ND1 110.5 REMARK 620 3 CYS A 222 O 102.2 103.9 REMARK 620 4 CYS A 222 SG 122.6 115.1 98.8 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 232 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 173 ND1 REMARK 620 2 HIS B 177 ND1 117.7 REMARK 620 3 CYS B 222 O 106.9 103.4 REMARK 620 4 CYS B 222 SG 131.0 103.2 87.2 REMARK 620 N 1 2 3 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 231 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 232 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD A 233 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CB1 A 235 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FAD B 234 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CB1 B 236 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1QR2 RELATED DB: PDB REMARK 900 HUMAN QUINONE REDUCTASE TYPE 2 REMARK 900 RELATED ID: 1SG0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF QR2 IN COMPLEX WITH RESVERATROL REMARK 900 RELATED ID: 1ZX1 RELATED DB: PDB REMARK 900 HUMAN QUINONE OXIDOREDUCTASE 2 (NQO2) IN COMPLEX WITH THE REMARK 900 CYTOSTATIC PRODRUG CB1954 REMARK 900 RELATED ID: 2QR2 RELATED DB: PDB REMARK 900 HUMAN QUINONE REDUCTASE TYPE 2, COMPLEX WITH MENADIONE DBREF 2BZS A -5 0 PDB 2BZS 2BZS -5 0 DBREF 2BZS A 1 230 UNP P16083 NQO2_HUMAN 1 230 DBREF 2BZS B -5 0 PDB 2BZS 2BZS -5 0 DBREF 2BZS B 1 230 UNP P16083 NQO2_HUMAN 1 230 SEQRES 1 A 236 CYS HIS ALA ILE ASN ALA ALA GLY LYS LYS VAL LEU ILE SEQRES 2 A 236 VAL TYR ALA HIS GLN GLU PRO LYS SER PHE ASN GLY SER SEQRES 3 A 236 LEU LYS ASN VAL ALA VAL ASP GLU LEU SER ARG GLN GLY SEQRES 4 A 236 CYS THR VAL THR VAL SER ASP LEU TYR ALA MET ASN PHE SEQRES 5 A 236 GLU PRO ARG ALA THR ASP LYS ASP ILE THR GLY THR LEU SEQRES 6 A 236 SER ASN PRO GLU VAL PHE ASN TYR GLY VAL GLU THR HIS SEQRES 7 A 236 GLU ALA TYR LYS GLN ARG SER LEU ALA SER ASP ILE THR SEQRES 8 A 236 ASP GLU GLN LYS LYS VAL ARG GLU ALA ASP LEU VAL ILE SEQRES 9 A 236 PHE GLN PHE PRO LEU TYR TRP PHE SER VAL PRO ALA ILE SEQRES 10 A 236 LEU LYS GLY TRP MET ASP ARG VAL LEU CYS GLN GLY PHE SEQRES 11 A 236 ALA PHE ASP ILE PRO GLY PHE TYR ASP SER GLY LEU LEU SEQRES 12 A 236 GLN GLY LYS LEU ALA LEU LEU SER VAL THR THR GLY GLY SEQRES 13 A 236 THR ALA GLU MET TYR THR LYS THR GLY VAL ASN GLY ASP SEQRES 14 A 236 SER ARG TYR PHE LEU TRP PRO LEU GLN HIS GLY THR LEU SEQRES 15 A 236 HIS PHE CYS GLY PHE LYS VAL LEU ALA PRO GLN ILE SER SEQRES 16 A 236 PHE ALA PRO GLU ILE ALA SER GLU GLU GLU ARG LYS GLY SEQRES 17 A 236 MET VAL ALA ALA TRP SER GLN ARG LEU GLN THR ILE TRP SEQRES 18 A 236 LYS GLU GLU PRO ILE PRO CYS THR ALA HIS TRP HIS PHE SEQRES 19 A 236 GLY GLN SEQRES 1 B 236 CYS HIS ALA ILE ASN ALA ALA GLY LYS LYS VAL LEU ILE SEQRES 2 B 236 VAL TYR ALA HIS GLN GLU PRO LYS SER PHE ASN GLY SER SEQRES 3 B 236 LEU LYS ASN VAL ALA VAL ASP GLU LEU SER ARG GLN GLY SEQRES 4 B 236 CYS THR VAL THR VAL SER ASP LEU TYR ALA MET ASN PHE SEQRES 5 B 236 GLU PRO ARG ALA THR ASP LYS ASP ILE THR GLY THR LEU SEQRES 6 B 236 SER ASN PRO GLU VAL PHE ASN TYR GLY VAL GLU THR HIS SEQRES 7 B 236 GLU ALA TYR LYS GLN ARG SER LEU ALA SER ASP ILE THR SEQRES 8 B 236 ASP GLU GLN LYS LYS VAL ARG GLU ALA ASP LEU VAL ILE SEQRES 9 B 236 PHE GLN PHE PRO LEU TYR TRP PHE SER VAL PRO ALA ILE SEQRES 10 B 236 LEU LYS GLY TRP MET ASP ARG VAL LEU CYS GLN GLY PHE SEQRES 11 B 236 ALA PHE ASP ILE PRO GLY PHE TYR ASP SER GLY LEU LEU SEQRES 12 B 236 GLN GLY LYS LEU ALA LEU LEU SER VAL THR THR GLY GLY SEQRES 13 B 236 THR ALA GLU MET TYR THR LYS THR GLY VAL ASN GLY ASP SEQRES 14 B 236 SER ARG TYR PHE LEU TRP PRO LEU GLN HIS GLY THR LEU SEQRES 15 B 236 HIS PHE CYS GLY PHE LYS VAL LEU ALA PRO GLN ILE SER SEQRES 16 B 236 PHE ALA PRO GLU ILE ALA SER GLU GLU GLU ARG LYS GLY SEQRES 17 B 236 MET VAL ALA ALA TRP SER GLN ARG LEU GLN THR ILE TRP SEQRES 18 B 236 LYS GLU GLU PRO ILE PRO CYS THR ALA HIS TRP HIS PHE SEQRES 19 B 236 GLY GLN HET ZN A 231 1 HET FAD A 233 53 HET CB1 A 235 18 HET ZN B 232 1 HET FAD B 234 53 HET CB1 B 236 18 HETNAM ZN ZINC ION HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM CB1 5-(AZIRIDIN-1-YL)-2,4-DINITROBENZAMIDE HETSYN CB1 CB1954; TRETAZICAR FORMUL 3 ZN 2(ZN 2+) FORMUL 4 FAD 2(C27 H33 N9 O15 P2) FORMUL 5 CB1 2(C9 H8 N4 O5) FORMUL 9 HOH *299(H2 O) HELIX 1 1 SER A 16 GLN A 32 1 17 HELIX 2 2 LEU A 41 ASN A 45 1 5 HELIX 3 3 THR A 51 ASP A 54 5 4 HELIX 4 4 ASN A 66 GLN A 77 1 12 HELIX 5 5 ALA A 81 ALA A 94 1 14 HELIX 6 6 PRO A 109 LEU A 120 1 12 HELIX 7 7 PHE A 131 GLY A 135 5 5 HELIX 8 8 THR A 151 THR A 156 5 6 HELIX 9 9 ASP A 163 HIS A 173 1 11 HELIX 10 10 ALA A 1 PHE A 178 1 178 HELIX 11 11 SER A 196 THR A 213 1 18 HELIX 12 12 ILE A 214 GLU A 217 5 4 HELIX 13 13 THR A 223 GLY A 229 1 7 HELIX 14 14 SER B 16 GLN B 32 1 17 HELIX 15 15 THR B 51 ASP B 54 5 4 HELIX 16 16 ASN B 66 GLN B 77 1 12 HELIX 17 17 ALA B 81 ALA B 94 1 14 HELIX 18 18 PRO B 109 LEU B 120 1 12 HELIX 19 19 PHE B 131 GLY B 135 5 5 HELIX 20 20 ASP B 163 HIS B 173 1 11 HELIX 21 21 LEU B 176 GLY B 180 5 5 HELIX 22 22 SER B 196 THR B 213 1 18 HELIX 23 23 ILE B 214 GLU B 217 5 4 HELIX 24 24 THR B 223 GLY B 229 1 7 SHEET 1 AA 5 THR A 35 ASP A 40 0 SHEET 2 AA 5 LYS A 4 TYR A 9 1 O VAL A 5 N THR A 37 SHEET 3 AA 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AA 5 LEU A 141 THR A 147 1 O LEU A 141 N VAL A 97 SHEET 5 AA 5 LYS A 182 VAL A 183 1 O LYS A 182 N ALA A 142 SHEET 1 AB 5 THR A 35 ASP A 40 0 SHEET 2 AB 5 LYS A 4 TYR A 9 1 O VAL A 5 N THR A 37 SHEET 3 AB 5 LEU A 96 PRO A 102 1 O LEU A 96 N LEU A 6 SHEET 4 AB 5 LEU A 141 THR A 147 1 O LEU A 141 N VAL A 97 SHEET 5 AB 5 GLN A 187 SER A 189 1 O GLN A 187 N VAL A 146 SHEET 1 BA 5 THR B 35 ASP B 40 0 SHEET 2 BA 5 LYS B 4 TYR B 9 1 O VAL B 5 N THR B 37 SHEET 3 BA 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BA 5 LEU B 141 THR B 147 1 O LEU B 141 N VAL B 97 SHEET 5 BA 5 LYS B 182 VAL B 183 1 O LYS B 182 N ALA B 142 SHEET 1 BB 5 THR B 35 ASP B 40 0 SHEET 2 BB 5 LYS B 4 TYR B 9 1 O VAL B 5 N THR B 37 SHEET 3 BB 5 LEU B 96 PRO B 102 1 O LEU B 96 N LEU B 6 SHEET 4 BB 5 LEU B 141 THR B 147 1 O LEU B 141 N VAL B 97 SHEET 5 BB 5 GLN B 187 SER B 189 1 O GLN B 187 N VAL B 146 LINK ND1 HIS A 173 ZN ZN A 231 1555 1555 1.93 LINK ND1 HIS A 177 ZN ZN A 231 1555 1555 2.14 LINK O CYS A 222 ZN ZN A 231 1555 1555 1.97 LINK SG CYS A 222 ZN ZN A 231 1555 1555 2.31 LINK ND1 HIS B 173 ZN ZN B 232 1555 1555 1.89 LINK ND1 HIS B 177 ZN ZN B 232 1555 1555 2.35 LINK O CYS B 222 ZN ZN B 232 1555 1555 1.92 LINK SG CYS B 222 ZN ZN B 232 1555 1555 2.43 CISPEP 1 ILE A 128 PRO A 129 0 4.37 CISPEP 2 ILE B 128 PRO B 129 0 4.33 SITE 1 AC1 3 HIS A 173 HIS A 177 CYS A 222 SITE 1 AC2 3 HIS B 173 HIS B 177 CYS B 222 SITE 1 AC3 26 ASN A 66 ASP A 117 CB1 A 235 HOH A2163 SITE 2 AC3 26 HOH A2164 HOH A2165 HOH A2166 HOH A2167 SITE 3 AC3 26 HIS B 11 LYS B 15 SER B 16 PHE B 17 SITE 4 AC3 26 ASN B 18 SER B 20 PRO B 102 LEU B 103 SITE 5 AC3 26 TYR B 104 TRP B 105 PHE B 106 THR B 147 SITE 6 AC3 26 THR B 148 GLY B 149 GLY B 150 TYR B 155 SITE 7 AC3 26 GLU B 193 ARG B 200 SITE 1 AC4 10 PHE A 126 PHE A 178 FAD A 233 HOH A2166 SITE 2 AC4 10 HOH A2167 TRP B 105 GLY B 149 GLY B 150 SITE 3 AC4 10 MET B 154 ASN B 161 SITE 1 AC5 24 HIS A 11 LYS A 15 SER A 16 PHE A 17 SITE 2 AC5 24 ASN A 18 SER A 20 PRO A 102 LEU A 103 SITE 3 AC5 24 TYR A 104 TRP A 105 PHE A 106 THR A 147 SITE 4 AC5 24 THR A 148 GLY A 149 GLY A 150 TYR A 155 SITE 5 AC5 24 GLU A 193 GLU A 197 ARG A 200 ASN B 66 SITE 6 AC5 24 ASP B 117 CB1 B 236 HOH B2131 HOH B2132 SITE 1 AC6 10 TRP A 105 GLY A 149 GLY A 150 MET A 154 SITE 2 AC6 10 ASN A 161 HOH A2141 PHE B 126 PHE B 178 SITE 3 AC6 10 FAD B 234 HOH B2021 CRYST1 80.830 106.110 61.650 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012372 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009424 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016221 0.00000